[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]  Ozmosi [@OzmosiHealth](/creator/twitter/OzmosiHealth) on x 2627 followers Created: 2025-07-10 12:32:31 UTC $ABBV AbbVie and Ichnos Glenmark Innovation (IGI) agree on exclusive global license for ISB 2001, a novel Trispecific Antibody targeting CD38, BCMA, and CD3. More Info: $XBI $IBB $XPH $PPH  XXX engagements  **Related Topics** [$pph](/topic/$pph) [$xph](/topic/$xph) [$ibb](/topic/$ibb) [$xbi](/topic/$xbi) [more info](/topic/more-info) [$abbv](/topic/$abbv) [stocks healthcare](/topic/stocks-healthcare) [Post Link](https://x.com/OzmosiHealth/status/1943287216513622157)
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Ozmosi @OzmosiHealth on x 2627 followers
Created: 2025-07-10 12:32:31 UTC
$ABBV AbbVie and Ichnos Glenmark Innovation (IGI) agree on exclusive global license for ISB 2001, a novel Trispecific Antibody targeting CD38, BCMA, and CD3.
More Info: $XBI $IBB $XPH $PPH
XXX engagements
Related Topics $pph $xph $ibb $xbi more info $abbv stocks healthcare
/post/tweet::1943287216513622157